1. 528 Sexual dimorphism in myeloid-derived suppressor cells promote GBM progression in females via IL-1b. (9th November 2020) Authors: Bayik, Defne; Zhou, Yadi; Park, Chihyun; Hong, Chngjin; Silver, Danielle; Watson, Dionysios; Lo, Alice; Hwang, Tae Hyun; Cheng, Feixiong; Sims, Peter; Iavarone, Antonio; Lathia, Justin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 528 Sexual dimorphism in myeloid-derived suppressor cells promote GBM progression in females via IL-1b. (9th November 2020) Authors: Bayik, Defne; Zhou, Yadi; Park, Chihyun; Hong, Chngjin; Silver, Danielle; Watson, Dionysios; Lo, Alice; Hwang, Tae Hyun; Cheng, Feixiong; Sims, Peter; Iavarone, Antonio; Lathia, Justin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ATIM-40. CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS PREDICT FAVORABLE RESPONSE TO IMMUNE CHECKPOINT THERAPY IN A RANDOMIZED TRIAL OF NIVOLUMAB AND BEVACIZUMAB IN RECURRENT GBM. (11th November 2019) Authors: Ahluwalia, Manmeet; Grabowski, Matthew; Alban, Tyler; Otvos, Balint; Bayik, Defne; Saeed Bamashmos, Anas; Rayman, Patricia; Diaz-Montero, Marcela; Reardon, David; Wen, Patrick; Peereboom, David; Lathia, Justin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. (October 2016) Authors: Watson, Dionysios C.; Bayik, Defne; Srivatsan, Avinash; Bergamaschi, Cristina; Valentin, Antonio; Niu, Gang; Bear, Jenifer; Monninger, Mitchell; Sun, Mei; Morales-Kastresana, Aizea; Jones, Jennifer C.; Felber, Barbara K.; Chen, Xiaoyuan; Gursel, Ihsan; Pavlakis, George N. Journal: Biomaterials Issue: Volume 105(2016) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. (October 2016) Authors: Watson, Dionysios C.; Bayik, Defne; Srivatsan, Avinash; Bergamaschi, Cristina; Valentin, Antonio; Niu, Gang; Bear, Jenifer; Monninger, Mitchell; Sun, Mei; Morales-Kastresana, Aizea; Jones, Jennifer C.; Felber, Barbara K.; Chen, Xiaoyuan; Gursel, Ihsan; Pavlakis, George N. Journal: Biomaterials Issue: Volume 105(2016) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA. (11th November 2019) Authors: Otvos, Balint; Grabowski, Matthew; Alban, Tyler; Golubovsky, Joshua; Neumann, Chase; Rabjlenovic, Anja; Bayik, Defne; Lauko, Adam; Bucala, Richard; Vogelbaum, Michael; Lathia, Justin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. IMMU-01. MYELOID-DERIVED SUPPRESSOR CELL HETEROGENEITY DRIVES GLIOBLASTOMA PROGRESSION IN A SEX-DEPENDENT MANNER. (11th November 2019) Authors: Bayik, Defne; Silver, Daniel; Park, Chihyun; Watson, Dionysios; Sorensen, Mia; Roversi, Gustavo; Lauko, Adam; Alban, Tyler; Lo, Alice; Sims, Peter; Barnholtz-Sloan, Jill; Kristensen, Bjarne; Hyun Hwang, Tae; Khalil, Ahmad; Iavarone, Antonio; Cheng, Feixiong; Lathia, Justin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IMMU-08. MODELING UPFRONT GLIOBLASTOMA SURGICAL RESECTION AND STEROID USE REVEALS IMMUNOSUPPRESSIVE CHANGES AND SUGGESTS THAT PERIPHERAL LYMPHOCYTE COUNTS ARE ASSOCIATED WITH TUMOR VOLUME AND PROGNOSIS. (9th November 2020) Authors: Otvos, Balint; Alban, Tyler; Grabowski, Matthew; Bayik, Defne; Winkelman, Robert; Johnson, Sarah; Rabljenovic, Anja; Vogelbaum, Michael; Ahluwalia, Manmeet; Fecci, Peter; Lathia, Justin Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IMMU-10. GENOMIC DIFFERENCES UNDERLIE MYELOID-DERIVED SUPPRESSOR CELL SEXUAL DIMORPHISM IN GLIOBLASTOMA. (9th November 2020) Authors: Bayik, Defne; Zhou, Yadi; Lo, Alice; Park, Chihyun; Hong, Changjin; Vail, Daniel; Watson, Dionysios; Roversi, Gustavo; Lauko, Adam; Silver, Daniel; Alban, Tyler; Otvos, Balint; Grabowski, Matthew; Sorensen, Mia; Sims, Peter; Kristensen, Bjarne; Horbinski, Craig; Vogelbaum, Michael; Hwang, Tae Hyu... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IMMU-17. LEVERAGING CORE EPIGENETIC PROGRAMMING OF IMMUNOSUPPRESSIVE MYELOID CELLS FOR THERAPEUTIC TARGETING OF GLIOBLASTOMA. (14th November 2022) Authors: Bayik, Defne; Bartels, Cynthia; Lovrenert, Katreya; Zhang, Duo; Watson, Dionysios; Kay, Kristen; Lee, Juyeun; Vogelbaum, Michael; Fan, Yi; Scacheri, Peter; Lathia, Justin Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗